Singapore markets closed

InMode Ltd. (INMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
83.37-1.81 (-2.12%)
At close: 4:00PM EDT
83.75 +0.38 (+0.46%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close85.18
Bid83.30 x 800
Ask83.75 x 800
Day's range82.63 - 86.40
52-week range18.02 - 90.00
Avg. volume1,938,243
Market cap6.368B
Beta (5Y monthly)1.65
PE ratio (TTM)55.77
EPS (TTM)1.50
Earnings date26 Oct 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est87.20
  • Motley Fool

    2 Stocks to Consider if Pfizer's and Moderna's CEOs Are Right That the Pandemic Could End Next Year

    The chief executive officers of both Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) have recently predicted that the pandemic could end by the end of 2022. In this Motley Fool Live video recorded on Sept. 29, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss two stocks to consider if the vaccine makers' CEOs are right.

  • Motley Fool

    Why InMode Stock Popped Today

    What happened  Shares of InMode (NASDAQ: INMD) leaped 8.6% on Tuesday after the medical technology specialist boosted its full-year financial forecast.  So what InMode anticipates third-quarter revenue of $93.

  • Motley Fool

    2 Top Healthcare Stocks to Buy for the Long Haul

    In my view, it's a lot easier to be patient with your stocks when they're strong performers right out of the gate as a result of an effective business model and firm fundamentals. Instead, check the business model and fundamentals, if those are solid, your underperforming new stock could be worth the wait with time. The two healthcare companies I'll be discussing today will probably continue to grow steadily over the next decade, just as they have in recent times.